BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2419 related articles for article (PubMed ID: 24141020)

  • 21. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
    Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
    J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1
    Ionescu A; Gradus T; Altman T; Maimon R; Saraf Avraham N; Geva M; Hayden M; Perlson E
    Cell Death Dis; 2019 Mar; 10(3):210. PubMed ID: 30824685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of glial fibrillary acidic protein marginally accelerates disease progression in a SOD1(H46R) transgenic mouse model of ALS.
    Yoshii Y; Otomo A; Pan L; Ohtsuka M; Hadano S
    Neurosci Res; 2011 Jul; 70(3):321-9. PubMed ID: 21453731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroNeurotrophins Improve Survival in Motor Neuron-Astrocyte Co-Cultures but Do Not Improve Disease Phenotypes in a Mutant SOD1 Mouse Model of Amyotrophic Lateral Sclerosis.
    Glajch KE; Ferraiuolo L; Mueller KA; Stopford MJ; Prabhkar V; Gravanis A; Shaw PJ; Sadri-Vakili G
    PLoS One; 2016; 11(10):e0164103. PubMed ID: 27716798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adipose-derived Stem Cell Conditioned Media Extends Survival time of a mouse model of Amyotrophic Lateral Sclerosis.
    Fontanilla CV; Gu H; Liu Q; Zhu TZ; Zhou C; Johnstone BH; March KL; Pascuzzi RM; Farlow MR; Du Y
    Sci Rep; 2015 Nov; 5():16953. PubMed ID: 26586020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
    Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
    Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis.
    Shibata N; Yamamoto T; Hiroi A; Omi Y; Kato Y; Kobayashi M
    Neuropathology; 2010 Aug; 30(4):353-60. PubMed ID: 19925559
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SA4503, a sigma-1 receptor agonist, suppresses motor neuron damage in in vitro and in vivo amyotrophic lateral sclerosis models.
    Ono Y; Tanaka H; Takata M; Nagahara Y; Noda Y; Tsuruma K; Shimazawa M; Hozumi I; Hara H
    Neurosci Lett; 2014 Jan; 559():174-8. PubMed ID: 24334165
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disruption of the astrocytic TNFR1-GDNF axis accelerates motor neuron degeneration and disease progression in amyotrophic lateral sclerosis.
    Brambilla L; Guidotti G; Martorana F; Iyer AM; Aronica E; Valori CF; Rossi D
    Hum Mol Genet; 2016 Jul; 25(14):3080-3095. PubMed ID: 27288458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of human mutated G93A SOD1 changes dynamics of the ER mitochondria calcium cycle specifically in mouse embryonic motor neurons.
    Lautenschläger J; Prell T; Ruhmer J; Weidemann L; Witte OW; Grosskreutz J
    Exp Neurol; 2013 Sep; 247():91-100. PubMed ID: 23578819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatocyte growth factor (HGF) attenuates gliosis and motoneuronal degeneration in the brainstem motor nuclei of a transgenic mouse model of ALS.
    Kadoyama K; Funakoshi H; Ohya W; Nakamura T
    Neurosci Res; 2007 Dec; 59(4):446-56. PubMed ID: 17935811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spinal cord pathology is ameliorated by P2X7 antagonism in a SOD1-mutant mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Parisi C; Matteucci A; Potenza RL; Armida M; Popoli P; D'Ambrosi N; Volonté C
    Dis Model Mech; 2014 Sep; 7(9):1101-9. PubMed ID: 25038061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
    Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered distribution and levels of cathepsinD and cystatins in amyotrophic lateral sclerosis transgenic mice: possible roles in motor neuron survival.
    Wootz H; Weber E; Korhonen L; Lindholm D
    Neuroscience; 2006 Dec; 143(2):419-30. PubMed ID: 16973300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
    Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
    Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Iron accumulation promotes TACE-mediated TNF-α secretion and neurodegeneration in a mouse model of ALS.
    Lee JK; Shin JH; Gwag BJ; Choi EJ
    Neurobiol Dis; 2015 Aug; 80():63-9. PubMed ID: 26002422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).
    Howland DS; Liu J; She Y; Goad B; Maragakis NJ; Kim B; Erickson J; Kulik J; DeVito L; Psaltis G; DeGennaro LJ; Cleveland DW; Rothstein JD
    Proc Natl Acad Sci U S A; 2002 Feb; 99(3):1604-9. PubMed ID: 11818550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NLRP3 inflammasome is expressed by astrocytes in the SOD1 mouse model of ALS and in human sporadic ALS patients.
    Johann S; Heitzer M; Kanagaratnam M; Goswami A; Rizo T; Weis J; Troost D; Beyer C
    Glia; 2015 Dec; 63(12):2260-73. PubMed ID: 26200799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The progesterone receptor agonist Nestorone holds back proinflammatory mediators and neuropathology in the wobbler mouse model of motoneuron degeneration.
    Meyer M; Gonzalez Deniselle MC; Garay L; Sitruk-Ware R; Guennoun R; Schumacher M; De Nicola AF
    Neuroscience; 2015 Nov; 308():51-63. PubMed ID: 26349009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 121.